The chart illustrate the money spent as percentage of Total Domestic Product (GDP) on medication over three years among several countries.
Overall, although there was a significant difference among countries to spent money on health, the trend withing a same state did not witnessed a remarkable change over recorded years. Switzerland and Belgium invested the highest assets, while Estonia stood at the bottom position for its expenditures.
Starting from the biggest categories, Switzerland invested around 11 percent of GDP in 2002, 2007, and 2012, followed by Belgium, which spent around 10 percent of money on medication fees in all observed years. For Denmark, figure soared from approximately 9% to around 10 in the subsequent years. In France, only 2007 was the year in which a cost exceeded 10% just like Switzerland. The funds allocated in Norway and Netherland remained between 8-10%,
Contrastigly, Estonia and Lithuania showed the least spending that was about 3% and 5%, respectively, in all years, the only exception for the latter countrys’ expenditure was the year 2012, in which figure rose to 6%. Meanwhile, Spain, Slovenia, Poland, and Luxembourg allocated the moderate amount of finances that ranged between 6-8%.
